These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 8070237

  • 1. The effects of dietary cholesterol on experimental diabetic nephropathy.
    Cooper ME, Vranes D, Vranes DA, Allen TJ, Panagiotopoulos S, Komers R, Jerums G.
    Diabetes Res; 1993; 22(4):159-69. PubMed ID: 8070237
    [Abstract] [Full Text] [Related]

  • 2. Disparate effects of castration on renal structure and function in the streptozotocin diabetic rat.
    Bach LA, Cooper ME, Vranes D, Allen TJ, Rumble J, Jerums G.
    Diabetes Res; 1994; 27(1):27-38. PubMed ID: 7648794
    [Abstract] [Full Text] [Related]

  • 3. C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats.
    Samnegård B, Jacobson SH, Jaremko G, Johansson BL, Ekberg K, Isaksson B, Eriksson L, Wahren J, Sjöquist M.
    Nephrol Dial Transplant; 2005 Mar; 20(3):532-8. PubMed ID: 15665028
    [Abstract] [Full Text] [Related]

  • 4. Effect of aspirin on experimental diabetic nephropathy.
    Moel DI, Safirstein RL, McEvoy RC, Hsueh W.
    J Lab Clin Med; 1987 Sep; 110(3):300-7. PubMed ID: 3475395
    [Abstract] [Full Text] [Related]

  • 5. Partial normalization by dietary cod-liver oil of increased microvascular albumin leakage in patients with insulin-dependent diabetes and albuminuria.
    Jensen T, Stender S, Goldstein K, Hølmer G, Deckert T.
    N Engl J Med; 1989 Dec 07; 321(23):1572-7. PubMed ID: 2685599
    [Abstract] [Full Text] [Related]

  • 6. Rapamycin prevents early steps of the development of diabetic nephropathy in rats.
    Yang Y, Wang J, Qin L, Shou Z, Zhao J, Wang H, Chen Y, Chen J.
    Am J Nephrol; 2007 Dec 07; 27(5):495-502. PubMed ID: 17671379
    [Abstract] [Full Text] [Related]

  • 7. Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats.
    Komers R, Schutzer W, Xue H, Oyama TT, Lindsley JN, Anderson S.
    Transl Res; 2007 Dec 07; 150(6):343-9. PubMed ID: 18022596
    [Abstract] [Full Text] [Related]

  • 8. Effects of oral zinc and magnesium supplementation on serum thyroid hormone and lipid levels in experimentally induced diabetic rats.
    Baydas B, Karagoz S, Meral I.
    Biol Trace Elem Res; 2002 Sep 07; 88(3):247-53. PubMed ID: 12350134
    [Abstract] [Full Text] [Related]

  • 9. Peanut (Arachis hypogaea) consumption improves glutathione and HDL-cholesterol levels in experimental diabetes.
    Emekli-Alturfan E, Kasikci E, Yarat A.
    Phytother Res; 2008 Feb 07; 22(2):180-4. PubMed ID: 17726728
    [Abstract] [Full Text] [Related]

  • 10. Hypolipidemic activity of 18beta-glycyrrhetinic acid on streptozotocin-induced diabetic rats.
    Kalaiarasi P, Kaviarasan K, Pugalendi KV.
    Eur J Pharmacol; 2009 Jun 10; 612(1-3):93-7. PubMed ID: 19361497
    [Abstract] [Full Text] [Related]

  • 11. Diabetic nephropathy in an aerobically trained rat model of diabetes.
    Albright AL, Mahan JD, Ward KM, Sherman WM, Roehrig KL, Kirby TE.
    Med Sci Sports Exerc; 1995 Sep 10; 27(9):1270-7. PubMed ID: 8531625
    [Abstract] [Full Text] [Related]

  • 12. Dietary polyunsaturated fatty acids slow the progression of diabetic nephropathy in streptozotocin-induced diabetic rats.
    Yokoyama M, Tanigawa K, Murata T, Kobayashi Y, Tada E, Suzuki I, Nakabou Y, Kuwahata M, Kido Y.
    Nutr Res; 2010 Mar 10; 30(3):217-25. PubMed ID: 20417883
    [Abstract] [Full Text] [Related]

  • 13. Combined effect of probucol and insulin on renal damage in diabetic rats fed a high cholesterol diet.
    Yoshida M, Kimura H, Kyuki K, Ito M.
    Eur J Pharmacol; 2006 Oct 24; 548(1-3):174-80. PubMed ID: 16979162
    [Abstract] [Full Text] [Related]

  • 14. High-fat diet in low-dose-streptozotocin-treated heminephrectomized rats induces all features of human type 2 diabetic nephropathy: a new rat model of diabetic nephropathy.
    Sugano M, Yamato H, Hayashi T, Ochiai H, Kakuchi J, Goto S, Nishijima F, Iino N, Kazama JJ, Takeuchi T, Mokuda O, Ishikawa T, Okazaki R.
    Nutr Metab Cardiovasc Dis; 2006 Oct 24; 16(7):477-84. PubMed ID: 17015185
    [Abstract] [Full Text] [Related]

  • 15. Serum cholesterol levels of nondiabetic and streptozotocin-diabetic rats fed a high cholesterol diet.
    Holmgren PR, Brown AC.
    Artery; 1993 Oct 24; 20(6):337-45. PubMed ID: 8010889
    [Abstract] [Full Text] [Related]

  • 16. Pravastatin modulates early diabetic nephropathy in an experimental model of diabetic renal disease.
    Casey RG, Joyce M, Roche-Nagle G, Chen G, Bouchier-Hayes D.
    J Surg Res; 2005 Feb 24; 123(2):176-81. PubMed ID: 15680375
    [Abstract] [Full Text] [Related]

  • 17. Effect of alpha-tocopherol supplementation on blood pressure and lipidic profile in streptozotocin-induced diabetes mellitus in spontaneously hypertensive rats.
    Vieira da Costa VA, Vianna LM.
    Clin Chim Acta; 2005 Jan 24; 351(1-2):101-4. PubMed ID: 15563877
    [Abstract] [Full Text] [Related]

  • 18. Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy.
    Awad AS, Huang L, Ye H, Duong ET, Bolton WK, Linden J, Okusa MD.
    Am J Physiol Renal Physiol; 2006 Apr 24; 290(4):F828-37. PubMed ID: 16332931
    [Abstract] [Full Text] [Related]

  • 19. Protective role of renal nerves in the development of diabetic nephropathy.
    Matsuoka H.
    Diabetes Res; 1993 Apr 24; 23(1):19-29. PubMed ID: 7924145
    [Abstract] [Full Text] [Related]

  • 20. YM440, a novel hypoglycemic agent, protects against nephropathy in Zucker fatty rats via plasma triglyceride reduction.
    Nakano R, Kurosaki E, Shimaya A, Kajikawa S, Shibasaki M.
    Eur J Pharmacol; 2006 Nov 07; 549(1-3):185-91. PubMed ID: 16989806
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.